Immunome Inc
NASDAQ:IMNM

Watchlist Manager
Immunome Inc Logo
Immunome Inc
NASDAQ:IMNM
Watchlist
Price: 19.57 USD 0.41%
Market Cap: 1.8B USD

Wall Street
Price Targets

IMNM Price Targets Summary
Immunome Inc

Wall Street analysts forecast IMNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMNM is 26.18 USD with a low forecast of 18.18 USD and a high forecast of 39.9 USD.

Lowest
Price Target
18.18 USD
7% Downside
Average
Price Target
26.18 USD
34% Upside
Highest
Price Target
39.9 USD
104% Upside
Immunome Inc Competitors:
Price Targets
AVCT
Avacta Group PLC
6% Upside
ELDN
Eledon Pharmaceuticals Inc
398% Upside
CMPX
Compass Therapeutics Inc.
143% Upside
VCEL
Vericel Corp
56% Upside
AMGN
Amgen Inc
3% Upside
KALV
Kalvista Pharmaceuticals Inc
87% Upside
VRTX
Vertex Pharmaceuticals Inc
9% Upside
9926
Akeso Inc
50% Upside

Revenue
Forecast

Revenue Estimate
Immunome Inc

The compound annual growth rate of Immunome Inc's revenue for the next 4 years is 110%.

N/A
Past Growth
110%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Immunome Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMNM's stock price target?
Price Target
26.18 USD

According to Wall Street analysts, the average 1-year price target for IMNM is 26.18 USD with a low forecast of 18.18 USD and a high forecast of 39.9 USD.

What is Immunome Inc's Revenue forecast?
Projected CAGR
110%

The compound annual growth rate of Immunome Inc's revenue for the next 4 years is 110%.

Back to Top